NIH-funded research R01 grant

Investigating how oxidative stress affects retinal damage in age-related macular degeneration.

Official title: cGAS signaling in oxidative retinal damage

Funded at Ohio State University · NIH-11027499 · Data updated 2026-11-12

This study is looking at how oxidative stress affects age-related macular degeneration (AMD), a common cause of vision loss, to find new ways to help slow down the damage to the retina, which could lead to better treatments for people with AMD.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$513,371
NIH project number1R01EY036873-01
Project IDNIH-11027499 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for or diagnosed with age-related macular degeneration.

Less likely to help

Patients with retinal conditions unrelated to oxidative stress or those without age-related macular degeneration may not benefit from this research.

What this research studies

This research focuses on understanding the role of oxidative stress in age-related macular degeneration (AMD), a leading cause of vision loss. It explores how oxidative stress triggers the release of self-DNA in retinal cells, activating an immune response pathway known as cGAS-STING. By using both chronic and acute mouse models, the study aims to uncover the mechanisms behind this process and identify potential therapeutic targets to slow down retinal degeneration. Patients may benefit from insights that could lead to new treatments for AMD.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that slow or prevent vision loss in patients with age-related macular degeneration.

How similar studies have gone: Previous research has shown promise in targeting oxidative stress pathways in retinal diseases, indicating potential for success in this approach.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Kerur, Nagaraj — Ohio State University
  • Study coordinator: Kerur, Nagaraj

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.